Home Search

gtbp - search results

If you're not happy with the results, please do another search
marijuana stocks

GT Biopharma Inc. (GTBP) Announces Agreement with a Major Pharmaceutical Company

GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug GT...
marijuana stocks news

 GT Biopharma Inc. (GTBP) Announces Dr. Raymond W Urbanski Elevated to Chief Executive Officer...

GT Biopharma Announces Dr. Raymond W Urbanski Elevated to Chief Executive Officer and Chairman of The Board  GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP) today...
marijuana stock news

GT Biopharma Inc. (GTBP) Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of...

GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) or the "Company", an...
marijuana stock news

GT Biopharma Inc. (GTBP) Announces Update to OXS-3550 IND Filing

GT Biopharma Announces Update to OXS-3550 IND Filing, Its Most Advanced Tri-specific Killer Engager GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris "GTBP.PA" or the...
marijuana stocks news

GT Biopharma Inc. (GTBP) Announces Dr. Raymond W Urbanski Elevated to President and Chief...

Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company GT Biopharma Inc. (GTBP)(Euronext Paris GTBP.PA) today announced...
marijuana stocks news

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma’s (GTBP) Board of...

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris "GTBP.PA") today announced...
marijuana stocks

GT Biopharma, Inc. (GTBP) Announces it has Completed Enrollment in Proof-of-concept Clinical Trial for...

GT Biopharma, Inc. Announces it has Completed Enrollment in Proof-of-concept Clinical Trial for its Novel Treatment for Motion Sickness GT Biopharma, Inc. announced today that...
marijuana stocks news

GT Biopharma Inc. (GTBP) Announces 50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel...

GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today that the Proof-of-Concept clinical trial with GTP-011, a novel treatment for the symptoms of motion...
marijuana stock news

GT Biopharma Inc. (GTBP) to Present at Roth Capital Partners 30th Annual Conference

GT Biopharma to Present at Roth Capital Partners 30th Annual Conference GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) today announced that Shawn Cross, Chairman and Chief...
marijuana stocks news

GT Biopharma (GTBP) Announces Appointment of Shawn M Cross as Chairman and Chief Executive...

WASHINGTON, DC, February 15, 2018 /PRNewswire/ -- GT Biopharma, Inc. (GTBP) (GTBP.PA) ("GT" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and...

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com